[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100461830":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":59,"collaborators":61,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":18,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":18,"enrollmentInfo":73,"targetDuration":18,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":85,"overallStatus":38,"whyStopped":18,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Case Western Reserve University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention: OPTIMA-BP Implementation","EXPERIMENTAL","Participants randomized to OPTIMA-BP intervention for 6 months then observed for a 6 month follow up period",[13],"Behavioral: OPTIMA-BP Intervention",{"label":15,"type":16,"description":17,"interventionNames":18},"Waitlist: OPTIMA-BP implementation","NO_INTERVENTION","Participants randomized to waitlist for 6 months, then offered the OPTIMA-BP intervention for 6 months.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","OPTIMA-BP Intervention","Participants will continue their regular medical care, supplemented by the OPTIMA-BP intervention:\n\n1. Six weekly web-based education sessions on hypertension management.\n2. Access to Medisafe, a medication management application (app) with a personalized medication adherence support (SMS reminder messages, adherence feedback, etc.) for 6 months.\n3. Home Blood Pressure Monitoring (Omron series 10 home BP monitor). Participants will be asked to monitor and record their BP, 2x daily (AM and PM), twice a week, in a tracking log for 6 months.\n4. Nurse Counseling Session with a research nurse for informal counseling, social support, and follow-up sessions regarding progress.\n5. Optimizing HTN Treatment with 208 AA participants, in conjunction with their physician to maintain treatment goal BP: \\\u003C 130\u002F80 mmHg. based on current HTN guidelines and study recommendations including chlorthalidone 12.5-25 mg\u002Fday or amlodipine 5-10 mg\u002Fday or as chosen by their doctor.",[9],[26],{"name":27,"affiliation":28,"role":29},"Carolyn Still, PhD","Case Western Reserve University, School of Nursing","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},"Carolyn Still, PHD","CONTACT","216-368-6338","carolyn.still@case.edu",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Cleveland","Ohio","44143","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-81.69541,41.4995,{"lat":48,"lon":47},[51,54,57],{"name":52,"role":33,"phone":34,"phoneExt":18,"email":53},"Carolyn Still","cwh11@case.edu",{"name":55,"role":33,"phone":56,"phoneExt":18,"email":18},"Mahbooh Rahman, MD","216-844-3798",{"name":58,"role":29,"phone":18,"phoneExt":18,"email":18},"Mahboob Rahman, MD",{"type":29,"investigatorFullName":52,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Associate Professor & Assistant Dean of Research",[62],{"name":63,"class":6},"University Hospitals Cleveland Medical Center","100461830","optimizing-technology-to-improve-medication-adherence-and-bp-control-optima-bp-100461830",false,"NCT05293756","OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)","OPtimizing Technology to Improve Medication Adherence and Blood Pressure Control","Inclusion Criteria:\n\n1. Self-identify as African American\n2. 50 years of age or older\n3. Diagnosed with hypertension, with a systolic blood pressure≥ 130 mmHg but less than 170 mmHg\n4. Prescribed at least two hypertensive, one of which is a diuretic\u002Fthiazide and or calcium channel blocker antihypertensive medication\n5. Own a smartphone with a data plan, the capability to download the Medisafe app, or view videos\n6. Able to read\u002Funderstand English\n\nExclusion Criteria:\n\n1. Unable to give informed consent or judged to have impaired cognitive ability or severe memory\n2. Currently using a medication management application (app)\n3. Experienced a major CVD event or procedure (e.g., myocardial infarction, stroke, heart surgery) within the past year\n4. Patients with a diagnosis of chronic kidney disease (defined as estimated glomerular filtration rate (eGFR) \\\u003C 60 ml\u002Fmin\u002F1.73m2) and\u002For receiving dialysis.","ALL","50 Years",{"count":74,"type":75},208,"ESTIMATED","INTERVENTIONAL",[78],"NA","Hypertension (HTN) has a greater impact on African Americans (AA) than any other U.S. racial group. Uncontrolled blood pressure (BP) contributes to higher rates of disability, death, and health resource use among AA. HTN is the single most influential risk factor for cardiovascular disease (CVD), as well as a risk factor for the incidence of stroke, diabetes, chronic kidney disease, and dementia. Importantly, older adults account for 15% of the U.S. population, and two-thirds of older adults over age 60 have HTN, with higher rates observed in AA older adults. Strategies to support self-managing HTN and BP control are crucial as the older population is projected to age considerably and become more racially and ethnically diverse. Research has documented the negative effects on health and health outcomes of poorly controlled BP and is one of the most important modifiable CVD risk factors. Lower BP targets will require aggressive management and an increase in antihypertensive medications. Therefore, to achieve lower targets in this population, greater efforts, including patient-centered methods will be needed to support self-managing HTN, especially in terms of medication adherence.\n\nAs we shifted into the digital age, the use of mHealth technologies (smart phones, applications, SMS or text messaging) has been a powerful approach and mechanism for the treatment and management of chronic diseases. However, behavioral interventions that incorporate technology do not reach minorities or disadvantaged AA older adults with HTN. OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) will leverage existing knowledge of effective technology-based components for HTN self-management to support and improve BP control using unique aspects of mHealth platforms in AA older adults. Findings from this study, if confirmed, will improve BP control and support self-managing HTN, as well as has the potential to close the health disparity gap between AA and non-AA older adults with HTN.",[81,82,83,84],"Hypertension","Self-Management","Technology","Quality of Life",[81,82,86],"Home Blood Pressure Monitoring","2026-03-30",{"date":89,"type":90},"2026-04-03","ACTUAL",{"date":92,"type":90},"2021-02-14",{"date":94,"type":75},"2027-05-31",{"name":5,"class":6},1]